US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 2.1300
  • -0.2200-9.36%
Close Oct 18 16:00 ET
  • 2.2000
  • +0.0700+3.29%
Post 20:01 ET
15.90MMarket Cap-663P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibikase Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 16, 20242024/Q10.000 / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 16, 20242024/Q10.000 / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Inhibikase Therapeutics Earnings Reports

  • Inhibikase Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:20 ET

  • Inhibikase Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 17:11 ET

  • Inhibikase Therapeutics | 10-K: FY2023 Annual Report

    Mar 27 16:12 ET

  • Inhibikase Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 11, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data